Affiliations 

  • 1 Department of Oral and Maxillofacial Pathology and Biology, Faculty of Dental Sciences, University of Lagos, Lagos, Nigeria. aakinshipo@unilag.edu.ng
  • 2 Bahrain Defence Force Royal Medical Services, Riffa, Bahrain
  • 3 Department of Oral and Maxillofacial Pathology, Lagos University Teaching Hospital (LUTH) Idi Araba Lagos, Idi-Araba, Nigeria
  • 4 Department of Oral and Maxillofacial Pathology and Biology, Faculty of Dental Sciences, University of Lagos, Lagos, Nigeria
  • 5 Department of Oral & Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong, Hong Kong
  • 6 Department of Oral and Maxillofacial Clinical Sciences, Faculty of Dentistry, Universiti Malaya, Kualalampur, Malaysia
  • 7 Department of Oral Medicine and Radiology, King George's Medical University, Lucknow, India. chaurasiaakhilanand49@gmail.com
Head Neck Pathol, 2025 Jan 07;19(1):2.
PMID: 39776309 DOI: 10.1007/s12105-024-01739-x

Abstract

OBJECTIVE: To analyze the frequency, clinical, histopathological, and radiological characteristics of ameloblastoma in Nigeria over the course of two decades.

STUDY DESIGN: A retrospective analysis was conducted on 371 cases at a Nigerian university hospital between 2000 and 2023. Age, gender, site, histological variants, tumor size and duration were analyzed. Statistical analyses included the Shapiro-Wilk test, Mann-Whitney U test, Chi-square test, and Spearman rank correlation analysis.

RESULTS: The median patient age was 30 years (mean age 32.2), with a male-to-female ratio of 1.12:1. 54.7% of cases occurred in young adults (age range 20-39 years). Among the lesions, 11.3% were in the maxilla and 88.7% in the mandible. Patients with mandibular lesions had a median age of 29 years, while those with maxillary lesions had a statistically significantly higher median age of 37.5 years p-value = 0.001. Median tumor size was 36 cm2 for the mandible and 24 cm2 for the maxilla (significant p-value of 0.002). There was no correlation between tumor size, age, or gender. However, there was a significant correlation between tumor size and the duration of the condition.

CONCLUSION: The study concludes that ameloblastoma is more frequent among younger individuals in Nigeria and often presents with larger tumor sizes, emphasizing the need for early detection and intervention.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.